Rnc Capital Management LLC Abb Vie Inc. Transaction History

Rnc Capital Management LLC

$1.84 Billion
Q3 2024

A detailed history of Rnc Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rnc Capital Management LLC holds 356,760 shares of ABBV stock, worth $62.9 Million. This represents 3.84% of its overall portfolio holdings.

Number of Shares

356,760

Previous 356,760 -0.0%

Holding current value

$62.9 Million

Previous $61.2 Million 15.13%

% of portfolio

3.84%

Previous 3.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $2.25 Million - $2.63 Million	14,553 Added 4.25%	356,760 $61.2 Million
Q1 2024 Aug 07, 2024	SELL	$159.82 - $182.1 $6.8 Million - $7.75 Million	-42,562 Reduced 11.06%	342,207 $62.3 Million
Q4 2023 Jan 17, 2024	BUY	$137.6 - $154.97 $21,190 - $23,865	154 Added 0.04%	384,769 $59.6 Million
Q3 2023 Dec 27, 2023	SELL	$133.59 - $154.65 $2.71 Million - $3.14 Million	-20,322 Reduced 5.02%	384,615 $57.3 Million
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $720,589 - $896,726	-5,438 Reduced 1.33%	404,937 $54.6 Million
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $2.5 Million - $2.88 Million	-17,312 Reduced 4.05%	410,375 $65.4 Million
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $295,845 - $354,795	2,139 Added 0.5%	427,687 $69.1 Million
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $430,679 - $493,961	3,209 Added 0.76%	425,548 $57.1 Million
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $1.01 Million - $1.29 Million	7,373 Added 1.78%	422,339 $64.7 Million
Q1 2022 Jul 22, 2022	SELL	$131.98 - $163.75 $23 Million - $28.5 Million	-173,907 Reduced 29.53%	414,966 $67.3 Million
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $303,597 - $384,138	-2,826 Reduced 0.48%	588,873 $79.7 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $609,246 - $691,586	5,726 Added 0.98%	591,699 $63.8 Million
Q2 2021 Jul 20, 2021	BUY	$105.21 - $117.21 $7.57 Million - $8.44 Million	71,969 Added 14.0%	585,973 $66 Million
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $977,988 - $1.08 Million	-9,560 Reduced 1.83%	514,004 $55.6 Million
Q4 2020 Jan 13, 2021	SELL	$80.49 - $108.67 $1.51 Million - $2.03 Million	-18,711 Reduced 3.45%	523,564 $56.1 Million
Q3 2020 Dec 03, 2020	SELL	$85.91 - $100.83 $3.24 Million - $3.81 Million	-37,772 Reduced 6.51%	542,275 $47.5 Million
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $614,106 - $821,766	8,370 Added 1.46%	580,047 $56.9 Million
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $6.5 Million - $9.86 Million	-100,790 Reduced 14.99%	571,677 $43.6 Million
Q4 2019 Mar 09, 2020	BUY	$72.13 - $90.25 $1.03 Million - $1.29 Million	14,333 Added 2.18%	672,467 $59.5 Million
Q3 2019 Jul 22, 2020	SELL	$62.98 - $75.72 $1.62 Million - $1.94 Million	-25,649 Reduced 3.75%	658,134 $49.8 Million
Q2 2019 Jul 25, 2019	BUY	$65.7 - $83.98 $12.8 Million - $16.4 Million	195,310 Added 39.98%	683,783 $49.7 Million
Q1 2019 Apr 18, 2019	BUY	$77.14 - $90.79 $23,527 - $27,690	305 Added 0.06%	488,473 $39.4 Million
Q4 2018 Jan 15, 2019	BUY	$77.85 - $96.01 $445,924 - $549,945	5,728 Added 1.19%	488,168 $45 Million
Q3 2018 Oct 25, 2018	BUY	$88.91 - $98.84 $367,376 - $408,406	4,132 Added 0.86%	482,440 $45.6 Million
Q2 2018 Jul 20, 2018	BUY	$89.78 - $106.23 $931,018 - $1.1 Million	10,370 Added 2.22%	478,308 $44.3 Million
Q1 2018 Apr 11, 2018	BUY	$92.01 - $123.21 $69,191 - $92,653	752 Added 0.16%	467,938 $44.3 Million
Q4 2017 Jan 17, 2018	SELL	$89.56 - $98.21 $199,629 - $218,910	-2,229 Reduced 0.47%	467,186 $45.2 Million
Q3 2017 Oct 16, 2017	SELL	$69.85 - $89.22 $16.2 Million - $20.7 Million	-231,911 Reduced 33.07%	469,415 $41.7 Million
Q2 2017 Aug 22, 2017	BUY	N/A	701,326	701,326 $50.9 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rnc Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rnc Capital Management LLC with notifications on news.

Account

Rnc Capital Management LLC Abb Vie Inc. Transaction History